OpenAI sued over epilepsy death after ChatGPT advised drug taper
San Francisco-based OpenAI and CEO Sam Altman have been sued over the death of a 31-year-old Seattle woman with epilepsy who stopped taking her antiseizure medication on a schedule ChatGPT allegedly designed. Qun Wan and Meiqin Xu, the parents of Bowen Wan, filed the wrongful death lawsuit Oct. 27 in San Francisco County Superior Court. […] The post OpenAI sued over epilepsy death after ChatGPT advised drug taper appeared first on Becker's Hospital Review | Healthcare News & Analy...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.